Home
Drugs
Targets
Pathways
Ontologies
Cyp450s
Adv.search
Help/FAQ

Drug Details

add
Name:TAZAROTENE
PubChem ID:5381
Pathway:Show KEGG pathways
InChI:InChI=1/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3
SMILES:CCOC(c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1)=O

Properties:
Formula:C21H21NO2SAtoms:25
Molecular Weight:351.462Rotatable Bonds:3
H-bond Acceptors:3H-bond Donors:0
logP:4.4315
Targets:
Synonyms:
118292-40-3
3-Pyridinecarboxylic acid,
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-, ethyl ester
3-Pyridinecarboxylic acid, 6-((3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl)-,ethyl ester
AGN 190168
AGN-190168
Avage
Avage (TN)
C086827
C12531
C21H21NO2S
CHEBI:32184
D01132
DB00799
Ethyl 6-((4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
ethyl 6-(2-(4,4-dimethylthiochroman-6-yl)ethynyl)nicotinate
ethyl 6-[(4,4-dimethyl-3,4-dihydro-2H-thiochromen-6-yl)ethynyl]nicotinate
ethyl 6-[2-(4,4-dimethylthiochroman-6-yl)ethynyl]pyridine-3-carboxylate
LS-130838
NCGC00167525-01
Suretin
TAZAROTENE
Tazarotene (JAN/USAN/INN)
Tazarotene [USAN:INN]
Tazorac
Tazoral
ZINC01542199
Zorac
ATC-Codes:
Side-Effects:
Side-EffectFrequency
erythema0.34
burning sensation0.26
dry skin0.16
pruritus0.1
irritation skin0.1
contact dermatitis0.08
acne0.03
rash0.03
dermatitis0
edema0
hyperpigmentation0
hypertriglyceridemia0
hemorrhage0
facial pain0
peripheral edema0